DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Difelikefalin
Difelikefalin
Peripheral Kappa Opioid Receptor Activation Drives Cold Hypersensitivity in Mice
Summary Analgesics Dec2019
Atopic Dermatitis - Ph 2 Trial Expected to Initiate Around Mid-Year 2019
Chapter 10
Modulation of the Mu and Kappa Opioid Axis for Treatment of Chronic Pruritus
Chronic Kidney Disease-Associated Pruritus
The Main Tea Eta a El Mattitauli Mali Malta
Regulatory Strategies for Promoting the Safe Use of Prescription Opioids and the Potential Impact of Overregulation
VFMCRP and Cara Therapeutics Announce European Medicines Agency Has Accepted to Review the Marketing Authorization Application for Difelikefalin
FAST FACTS and CONCEPTS #408 CONSERVATIVE MANAGEMENT of PATIENTS with END STAGE RENAL DISEASE Antonio Corona MD and April Bigelow Phd, AGPCNP-BC
Symptom Management in CKD and Dialysis
Neuropathic Itch
Drug Pipeline Monthly Update June 2021
Efficacy and Safety of Difelikefalin in Patients Undergoing Hemodialysis with Pruritus: Results from a Phase 3 Randomized, Controlled Study (KALM-1)
Stembook 2018.Pdf
CR845 (Difelikefalin), a Kappa Receptors Agonist in Phase III by CARA Therapeutics: a Case of ‘Spin’ in Scientific Writing?
Ulipristal Acetate
“Synthesis and Biological Evaluation of the Antioxidant Properties of New
Top View
Opioid Receptor
Novel Analgesics with Peripheral Targets
The Role of Kappa- and Mu-Opioid Receptors in Pruritus Brian S
Attenuation of Morphine Tolerance, Reward, and Spinal Gliosis in Neuropathic Pain by Ultra-Low Dose Alpha2-Adrenergic Antagonists
Form 8-K Cara Therapeutics, Inc
Bioactive Compound Library Plus (96-Well)
A View Into Upcoming Specialty & Traditional Drugs
( 12 ) United States Patent
Strategies for Developing Kappa Opioid Receptor Agonists for the Treatment of Pain with Fewer Side-Effects
Rxoutlook® 2Nd Quarter 2021
En Busca Del Opioide Ideal. Nuevas Moléculas
阿片受体激动剂研究进展advances in Research on Opioid Receptor
WO 2017/015309 Al 26 January 2017 (26.01.2017) P O P C T
Uraemic Pruritus
KORSUVA (Difelikefalin) Is a Kappa Opioid Receptor Agonist
Opioid Receptor Inhibitors (Inhibitors, Agonists and Modulators)
A View Into Upcoming Specialty and Traditional Drugs JANUARY 2019
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
MGL-3196] Selective Agonist
Cara Therapeutics 2021 R&D Day Presentation
P36885 Cara Therapeutics, Inc. 10K 2020 V1